Vaccine development for H7N9 flu moving forward

PROVIDENCE – It has been a very busy month and half for Dr. Anne S. De Groot and her team at EpiVax, a bioscience firm based in the Knowledge District, which celebrated its 15th birthday on May 17. De Groot, the chief science officer and CEO of EpiVax, told Providence Business News that four new…

Register to keep reading or subscribe today and receive unlimited access at a special discounted rate in honor of our 35th anniversary.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display